Laura Newman
I am a medical journalist and blogger. My stories have appeared in peer-reviewed journals and on the web. In Patient POV, I strive to bring the same rigor to telling stories about patients that I have shown in my previous work, which has featured research scientists and physicians.
Laura can be found on Twitter as @lauranewmanny.Donate
If you like what you've been reading, please consider supporting this work.
Patient POVI’m on ScienceSeeker
-
Recent Posts
Recent Comments
- Pascale Lane, MD on Personalized Medicine: Read the Chart!
- Ricki Lewis on Personalized Medicine: Read the Chart!
- Jeanne Erdmann on Personalized Medicine: Read the Chart!
- mary on Will Patients Win with Transparent Hospital-Bill Mandates?
- Dev Rogers on Will Patients Win with Transparent Hospital-Bill Mandates?
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
Tags
access to care Alzheimer's disease bariatric surgery Brooklyn Centers for Medicare and Medicaid clinical trials CMS comparative effectiveness research conflict of interest contraception dementia diabetes drug costs elderly emergency care FDA haiku healthcare reform health insurance HHS Institute of Medicine Medicare metal-on-metal hips minorities Obama ophthalmology patient-centered outcomes research patient participation patient POV patient stories PCORI postmarketing surveillance prevention prostate cancer PSA research research priorities screening stigma testosterone replacement therapy transparency treatment USPSTF vaccines women's health
Monthly Archives: November 2012
Why Sanofi’s Zaltrap Deal Won’t Help Patients
Tweet I got excited when I read the New York Times story Nov. 9 (“Sanofi Halves Price of Cancer Drug Zaltrap After Sloan-Kettering Rejection)”. Zaltrap is an intravenous infusion drug for metastatic colorectal cancer. It is used for advanced cancer … Continue reading
Posted in Drug costs
Tagged colon cancer, copays, pharmaceutical companies, Sanofi, value-based healthcare, Zaltrap
1 Comment
Mental Health for the 99% Following Hurricane Sandy
Tweet Two weeks after Hurricane Sandy and a Nor’Easter that left thousands of New Yorkers without light, heat, and power for weeks, many New Yorkers were understandably shaken. Some had endured 911 and the disruption, though of an entirely different … Continue reading
Posted in Access to care, mental health
Tagged Hurricane Sandy, physician shortage, posttraumatic stress disorder
8 Comments
Top 10 Issues Driving My Vote for Obama
Tweet Obamacare Upcoming Supreme Court appointments Roe v. Wade Same sex marriage Preservation of Medicare and Medicaid Planned Parenthood The Dream Act Climate change Lily Ledbetter Act Saving FEMA This list is hardly exhaustive. Got friends or relatives wavering this … Continue reading
Posted in Medicaid, Medicare, Roe, voting
Tagged ACA, climate change, Obamacare, Supreme Court
Leave a comment